Results 31 to 40 of about 5,423,376 (380)
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.
New England Journal of Medicine, 2021 BACKGROUND Tirzepatide is a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist that is under development for the treatment of type 2 diabetes.
J. Frias +8 more
semanticscholar +1 more source
Facilitators and barriers of adaptation to diabetes: experiences of Iranian patients [PDF]
, 2014 Background: Diabetes mellitus is one of the most challenging and burdensome chronic diseases of the 21st century and More than 1% of the Iranian urban population older than 20 years develops Type 2 diabetes each year.
Arshadi Bostanabad, M. +4 more
core +2 more sources
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.
New England Journal of Medicine, 2020 BACKGROUND Finerenone, a nonsteroidal, selective mineralocorticoid receptor antagonist, reduced albuminuria in short-term trials involving patients with chronic kidney disease (CKD) and type 2 diabetes.
G. Bakris +10 more
semanticscholar +1 more source
Type 2 diabetes in children [PDF]
BMJ, 2001 Type 2 diabetes mellitus in children is an emotionally charged issue and an emerging public health problem. 1 2 Until recently most children with diabetes mellitus had type 1, one of the most common3 and increasingly prevalent4 chronic diseases in children.
Anne Fagot-Campagna +2 more
openaire +3 more sources
Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement [PDF]
, 2015 AIMS: To describe and to characterize clinical features of latent autoimmune diabetes in adults (LADA) compared to type 1 and type 2 diabetes in the UAE.
Al Tikriti, Alia +5 more
core +3 more sources
European Journal of Inflammation, 2013 Thyroid Associated Ophthalmopathy (TAO) is a complex pathology to treat and a considerable threat for Graves' Disease (GD) patients. Thus, there is great interest to find tools able to predict the onset and prognosis of TAO.
R. Bei +14 more
doaj +1 more source
Diabetes Care, 2018 The American Diabetes Association and the European Association for the Study of Diabetes convened a panel to update the prior position statements, published in 2012 and 2015, on the management of type 2 diabetes in adults.
M. Davies +9 more
semanticscholar +1 more source
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.
New England Journal of Medicine, 2021 BACKGROUND Finerenone, a selective nonsteroidal mineralocorticoid receptor antagonist, has favorable effects on cardiorenal outcomes in patients with predominantly stage 3 or 4 chronic kidney disease (CKD) with severely elevated albuminuria and type 2 ...
B. Pitt +10 more
semanticscholar +1 more source
Hypoglycaemia in Type 2 diabetes [PDF]
Diabetic Medicine, 2008 AbstractThe primary cause of hypoglycaemia in Type 2 diabetes is diabetes medication—in particular, those which raise insulin levels independently of blood glucose, such as sulphonylureas (SUs) and exogenous insulin. The risk of hypoglycaemia is increased in older patients, those with longer diabetes duration, lesser insulin reserve and perhaps in the ...
Amiel, S A +3 more
openaire +4 more sources
The association between neighbourhood greenspace and type 2 diabetes in a large cross-sectional study [PDF]
, 2014 Objective: To investigate the relationship between neighbourhood greenspace and type 2 diabetes. Design: Cross-sectional. Setting: 3 diabetes screening studies conducted in Leicestershire, UK in 2004–2011.
Astell-Burt +38 more
core +1 more source